Theodore E. Liston - Concepedia

Author

Theodore E. Liston

Pfizer (United States)ORCID

Also Known As

T E Liston, T. E. LISTON, T. E. Liston, T. LISTON, Theodore E Liston, Theodore E. Liston, Theodore Liston

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Vanderbilt University The University of Texas Health Science Center at San Antonio University of Warwick

About

Theodore E. Liston is an author at Pfizer (United States) specializing in medicine, pharmacology, and metabolism.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	1.6K
2	Health Sciences	4	4	344
3	Engineering	1	1	103
4	Natural Sciences	1	1	75
5	Social Sciences	1	1	20

Theodore E. Liston

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. R. Scott Obach, James G. Baxter, Theodore E. Liston, PubMed	1997	638
The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data R. Scott Obach, James G. Baxter, Theodore E. Liston, Journal of Pharmacology and Experimental Therapeutics Pharmacokinetic ModelingPreclinical Drug EvaluationPhysiologically-based Pharmacokinetic ModelingHuman Pharmacokinetic ParametersVitro Metabolism Data	1997	574
Development of a new permeability assay using low‐efflux MDCKII cells Li Di, Carrie Whitney‐Pickett, John P. Umland, Journal of Pharmaceutical Sciences Membrane TransportMembrane BiologyBiomedical EngineeringCellular BiochemistryMembrane Permeation	2011	311
Species Independence in Brain Tissue Binding Using Brain Homogenates Li Di, John P. Umland, George Chang, Drug Metabolism and Disposition	2011	158
Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI Patrick D. Lyden, Alastair M. Buchan, Johannes Boltze, Stroke	2021	150
Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Theodore E. Liston, Lisa Roberts Proceedings of the National Academy of Sciences Unique ProstaglandinMetabolomic ProfilingCarbonyl MetabolismMolecular PharmacologyMetabolic Syndrome	1985	135
Metabolic fate of radiolabeled prostaglandin D2 in a normal human male volunteer. Theodore E. Liston, L. Jackson Roberts Journal of Biological Chemistry Metabolic FateMetabolic DisorderInfused RadioactivityMetabolic SyndromeMedicinal Chemistry	1985	103
A High-Capacity LC/MS System for the Bioanalysis of Samples Generated from Plate-Based Metabolic Screening John Janiszewski, Katrina J. Rogers, Kevin M. Whalen, Analytical Chemistry EngineeringSample TreatmentSamples GeneratedBiological Mass SpectrometryMetabolomic Profiling	2001	103
Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteers Renli Teng, Stephen Harris, David E. Nix, Journal of Antimicrobial Chemotherapy Single Oral DosesAntimicrobial ChemotherapyTerminal-phase Half-lifeDrug ResistanceAntimicrobial Stewardship	1995	89
Discovery of the Hemifumarate and (α-<scp>l</scp>-Alanyloxy)methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group Ralph P. Robinson, Lawrence A. Reiter, Wayne E. Barth, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryAntirheumatic OxindolePharmacotherapyExperimental Pharmacology	1996	75

Page 1